Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 672 entries
View as:

Safety and Efficacy Study of Switching From Epzicom to Truvada

Phase: N/A Priority: Normal
NCT ID: NCT00724711 Org: User:
Start: 07/31/08 End: 04/30/11 Due: 04/30/12

ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla

Phase: N/A Priority: Normal
NCT ID: NCT00615745 Org: User:
Start: 04/30/08 End: 12/31/10 Due: 12/31/11

The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002379 Org: User:
Start: - End: - Due: -

Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT02071082 Org: User:
Start: 02/25/14 End: 10/26/16 Due: 10/26/17

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)

Phase: N/A Priority: Normal
NCT ID: NCT03046056 Org: User:
Start: 04/11/17 End: 07/20/20 Due: 07/20/21

Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01393106 Org: User:
Start: 09/30/11 End: 08/31/14 Due: 08/31/15

CRITIC - Treatment of Candidemia and Invasive Candidiasis

Phase: N/A Priority: Normal
NCT ID: NCT00670657 Org: User:
Start: 05/31/07 End: 01/31/09 Due: 01/31/10

Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection

Phase: N/A Priority: Normal
NCT ID: NCT01435044 Org: User:
Start: 09/30/11 End: 05/31/13 Due: 05/31/14

Study of Novel Treatment Combinations in Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05633667 Org: User:
Start: 03/16/23 End: 01/31/27 Due: 01/31/28

Study of Ambrisentan in Participants With Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00777920 Org: User:
Start: 11/17/08 End: 09/11/19 Due: 09/11/20

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02201953 Org: User:
Start: 07/31/14 End: 12/31/15 Due: 12/31/16

Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT01780506 Org: User:
Start: 12/26/12 End: 09/06/17 Due: 09/06/18

Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02959138 Org: User:
Start: 11/21/16 End: 10/05/18 Due: 10/05/19

Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants

Phase: N/A Priority: Normal
NCT ID: NCT01815736 Org: User:
Start: 03/27/13 End: 04/01/20 Due: 04/01/21

Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05165771 Org: User:
Start: 07/31/22 End: 03/31/23 Due: 03/31/24

Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406

Phase: N/A Priority: Normal
NCT ID: NCT04467684 Org: User:
Start: 07/07/20 End: 06/06/21 Due: 06/06/22

Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United States

Phase: N/A Priority: Normal
NCT ID: NCT00936715 Org: User:
Start: 08/31/09 End: 11/30/15 Due: 11/30/16

Study of Cilofexor in Adults With Primary Sclerosing Cholangitis

Phase: N/A Priority: Normal
NCT ID: NCT03890120 Org: User:
Start: 03/27/19 End: 12/23/22 Due: 12/23/23

Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies

Phase: N/A Priority: Normal
NCT ID: NCT01625338 Org: User:
Start: 06/30/12 End: 12/31/14 Due: 12/31/15

Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults

Phase: N/A Priority: Normal
NCT ID: NCT01967940 Org: User:
Start: 10/25/13 End: 07/31/17 Due: 07/31/18

Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)

Phase: N/A Priority: Normal
NCT ID: NCT03285711 Org: User:
Start: 10/06/17 End: 02/03/20 Due: 02/03/21

An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options

Phase: N/A Priority: Normal
NCT ID: NCT00042393 Org: User:
Start: - End: - Due: -

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02886728 Org: User:
Start: 08/08/16 End: 05/08/19 Due: 05/08/20

A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01850212 Org: User:
Start: 02/28/13 End: 10/31/14 Due: 10/31/15

Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02400307 Org: User:
Start: 04/17/15 End: 07/13/15 Due: 07/13/16